Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing
- PMID: 26969667
- DOI: 10.1007/s11684-016-0436-0
Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing
Abstract
The latent expression pattern of Epstein-Barr Virus (EBV) genes in nasopharyngeal carcinoma (NPC) has been extensively investigated, and the expression of several lytic genes in NPC has been reported. However, comprehensive information through EBV transcriptome analysis in NPC is limited. We performed paired-end RNA-seq to systematically and comprehensively characterize the expression of EBV genes in NPC tissue and C666-1 NPC cell line, which consistently carries EBV. In addition to the transcripts restricted to type II latency infection, the type III latency EBNA3s genes and a substantial number of lytic genes, such as BZLF1, BRLF1, and BMRF1, were detected through RNA-seq and were further verified in C666-1 cells and NPC tissue through realtime PCR.We also performed clustering analysis to classify NPC patient groups in terms of EBV gene expression, which presented two subtypes of NPC samples. Results revealed interesting patterns of EBV gene expression in NPC patients. This clustering was correlated with many signaling pathways, such as those related to heterotrimeric G-protein signaling, inflammation mediated by chemokine and cytokine signaling, ribosomes, protein metabolism, influenza infection, and ECM-receptor interaction. Our combined findings suggested that the expression of EBV genes in NPC is restricted not only to type II latency genes but also to type III latency and lytic genes. This study provided further insights into the potential role of EBV in the development of NPC.
Keywords: Epstein-Barr virus; latency genes; lytic genes; nasopharyngeal carcinoma; paired-end transcriptome sequencing.
Similar articles
-
Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis.J Gen Virol. 2000 Oct;81(Pt 10):2417-2423. doi: 10.1099/0022-1317-81-10-2417. J Gen Virol. 2000. PMID: 10993929
-
Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.J Gene Med. 2008 Oct;10(10):1124-33. doi: 10.1002/jgm.1237. J Gene Med. 2008. PMID: 18642396
-
Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.Clin Cancer Res. 2008 Feb 15;14(4):984-94. doi: 10.1158/1078-0432.CCR-07-0828. Clin Cancer Res. 2008. PMID: 18281530
-
Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation.Viruses. 2021 Nov 23;13(12):2344. doi: 10.3390/v13122344. Viruses. 2021. PMID: 34960613 Free PMC article. Review.
-
Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.Mol Pathol. 2000 Oct;53(5):248-54. doi: 10.1136/mp.53.5.248. Mol Pathol. 2000. PMID: 11091848 Free PMC article. Review.
Cited by
-
Detection of Epstein-Barr Virus in Periodontitis: A Review of Methodological Approaches.Microorganisms. 2020 Dec 29;9(1):72. doi: 10.3390/microorganisms9010072. Microorganisms. 2020. PMID: 33383930 Free PMC article. Review.
-
Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis.Proc Natl Acad Sci U S A. 2017 Sep 5;114(36):9683-9688. doi: 10.1073/pnas.1705236114. Epub 2017 Aug 22. Proc Natl Acad Sci U S A. 2017. PMID: 28831010 Free PMC article.
-
The microdissected gene expression landscape of nasopharyngeal cancer reveals vulnerabilities in FGF and noncanonical NF-κB signaling.Sci Adv. 2022 Apr 8;8(14):eabh2445. doi: 10.1126/sciadv.abh2445. Epub 2022 Apr 8. Sci Adv. 2022. PMID: 35394843 Free PMC article.
-
BRLF1 suppresses RNA Pol III-mediated RIG-I inflammasome activation in the early EBV lytic lifecycle.EMBO Rep. 2021 Jan 7;22(1):e50714. doi: 10.15252/embr.202050714. Epub 2020 Nov 23. EMBO Rep. 2021. PMID: 33225563 Free PMC article.
-
Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma.Comput Math Methods Med. 2022 Apr 25;2022:1941412. doi: 10.1155/2022/1941412. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Jun 28;2023:9781420. doi: 10.1155/2023/9781420 PMID: 35509856 Free PMC article. Retracted.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources